Enhancement of L-3-hydroxybutyryl-CoA dehydrogenase activity and circulating ketone body levels by pantethine. Relevance to dopaminergic injury.
about
Metabolic changes and inflammation in cultured astrocytes from the 5xFAD mouse model of Alzheimer's disease: Alleviation by pantethine.SILEC: a protocol for generating and using isotopically labeled coenzyme A mass spectrometry standardsPantethine treatment is effective in recovering the disease phenotype induced by ketogenic diet in a pantothenate kinase-associated neurodegeneration mouse model.Pantethine Alters Lipid Composition and Cholesterol Content of Membrane Rafts, With Down-Regulation of CXCL12-Induced T Cell Migration.Pantethine Down-Regulates Leukocyte Recruitment and Inflammatory Parameters in a Mouse Model of Allergic Airway Inflammation.Application of Metabolomics in Alzheimer's Disease.Activating cardiac E2F1 induces up-regulation of pyruvate dehydrogenase kinase 4 in mice on a short term of high fat feeding.
P2860
Q33565510-35C4605F-4684-4A27-84DD-B66C2C29E40DQ37242476-2F2FD8D8-D899-45F3-98FB-4B3F9A12DC9BQ37477342-CFE485E5-3DE2-45AA-AFFA-5C2DBCF0657AQ38904933-5B485EEA-73EF-4A86-A8C4-27A22589C8CFQ47137222-40286F8E-4D9C-4C15-8997-953DA34F2EF7Q49464422-95DB7173-DEBB-4E8A-A939-E1E1093CE849Q54512314-9F973F3B-F397-46D1-BBC1-5577BE3ADA51
P2860
Enhancement of L-3-hydroxybutyryl-CoA dehydrogenase activity and circulating ketone body levels by pantethine. Relevance to dopaminergic injury.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Enhancement of L-3-hydroxybuty ...... evance to dopaminergic injury.
@ast
Enhancement of L-3-hydroxybuty ...... evance to dopaminergic injury.
@en
Enhancement of L-3-hydroxybuty ...... evance to dopaminergic injury.
@nl
type
label
Enhancement of L-3-hydroxybuty ...... evance to dopaminergic injury.
@ast
Enhancement of L-3-hydroxybuty ...... evance to dopaminergic injury.
@en
Enhancement of L-3-hydroxybuty ...... evance to dopaminergic injury.
@nl
prefLabel
Enhancement of L-3-hydroxybuty ...... evance to dopaminergic injury.
@ast
Enhancement of L-3-hydroxybuty ...... evance to dopaminergic injury.
@en
Enhancement of L-3-hydroxybuty ...... evance to dopaminergic injury.
@nl
P2093
P2860
P356
P1433
P1476
Enhancement of L-3-hydroxybuty ...... evance to dopaminergic injury.
@en
P2093
André Nieoullon
Bouchra Gharib
Emilie Cornille
Max de Reggi
Mhamad Abou-Hamdan
Michel Khrestchatisky
P2860
P2888
P356
10.1186/1471-2202-11-51
P577
2010-04-23T00:00:00Z
P5875
P6179
1006513038